Sigrid Therapeutics

The company develops SiPore®, a patented bioengineered silica technology that entraps digestive enzymes in the gut to slow the digestion of carbohydrates and fats. Its product portfolio includes Carb Fence, a medical food for prediabetes and diabetes management, and Glucose Stabiliser, a consumer supplement for blood sugar and weight support. The technology is designed to reduce glucose and lipid spikes without systemic absorption, targeting the medical, consumer health, oral care, and veterinary markets.